Home » Topics » BioWorld Science

BioWorld Science
RSS

Bispecific CD80-IgG4 Fc-IL2V fusion protein shows antitumor activity

Oct. 11, 2019

Calling bias sinks CCR5 work, but is "likely unique" to variant

Oct. 10, 2019

Rubius initiates first-in-human study of RTX-135 for phenylketonuria

Oct. 10, 2019

MIF may contribute to disseminated coccidioidomycosis susceptibility

Oct. 10, 2019

New phase I study evaluates birinapant and radiation therapy in head and neck cancer

Oct. 10, 2019

DSMB recommends continuation of phase IIa study of montelukast VersaFilm in Alzheimer's disease

Oct. 10, 2019

FDA approves PF-708 for osteoporosis

Oct. 10, 2019

AgenTus Therapeutics develops T-cell receptor candidate targeting NY-ESO-1

Oct. 10, 2019

Affimed Therapeutics divulges EGFR- and CD16A-targeting proteins

Oct. 10, 2019

Evelo Biosciences presents new Tyzzerella nexilis bacterial compositions

Oct. 10, 2019

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...